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ABSTRACT
The lack of rapid and standardized tests for diagnosing Mycoplasma pneumoniae (M. pneumoniae) respiratory tract infections is a common problem in many countries. This prospective study
was conducted to determine the prevalence of M. pneumoniae using classical enzyme-linked immunosorbent assay (ELISA) and nested polymerase chain reaction (PCR) techniques among patients
with respiratory tract infections in Nablus District. The study included 129 patients who visited or
were admitted to the involved clinics. At first visit to clinical settings, a throat swab was collected
from all participants and serum specimens were collected from 103 patients. A second serum specimen was available for 16 patients. Throat swab specimens were tested by nested PCR for the detection of M. pneumoniae. Serum samples were tested for the presence of IgG and IgM antibodies
by ELISA. Out of 129 examined throat swab specimens, M. pneumoniae was detected by PCR in
15(11.6%) samples. M. pneumoniae specific IgM was detected in 4(3.9%) out of the 103 first serum
samples. A total of 47(45.6%) patients possessed IgG in the first and/or second serum specimens.
According to the applied diagnostic criteria (at least 2 positive tests), 10(7.8%) patients were diagnosed with current M. pneumoniae infection. The sensitivity of PCR was higher (100%) than that
of ELISA-IgM (40%) in the first serum specimen. Most of M. pneumoniae infections were diagnosed
during winter (8 out of the 10 cases). The highest percentage of M. pneumoniae respiratory infection
(11.3%) was found in patients with the age range 25-64 years. There were no significant differences
in the frequency of signs and symptoms in patients with M. pneumoniae infection compared to those
with other infectious agents. The frequency of increase in WBCs and granulocytes counts were
significantly lower in patients with M. pneumoniae infection (P = 0.006 and <0.001, respectively)
compared to other infectious agents. While, frequency of increase in lymphocyte count in patients
with M. pneumoniae infection was significantly (P=0.001) higher. In conclusion, M. pneumoniae
seems to be an important etiological agent in respiratory tract infections in the area, thus more attention is required in adopting health policy for diagnosis and used medication policies.
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INTRODUCTION
The most common reasons for doctor visits are respiratory tract infections and common
cold, which result in missed work or school
[1]. M. pneumoniae infection is associated
with mild acute respiratory infections such as
sore throat, pharyngitis, rhinitis, and tracheobronchitis, however, it can also cause more
critical infections including pneumonia or
lung abscess [2, 3].

M. pneumoniae respiratory tract infection
occurs in persons of all ages, but is most common among children and young adults [4, 5].
M. pneumoniae lack a cell wall [2], which
makes the bacteria resistant to β-lactam antibiotics, are not stained with Gram stain [6] and
makes these organisms pleomorphic [7]. Culture of M. pneumoniae from clinical specimens is rarely performed in a routine context
because it requires specialized media and its
time consuming, where it takes up to 21 days
to obtain a visible colony [8, 9].
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Patients with M. pneumoniae respiratory
infection show clinical presentations not significantly different from those of patients with
respiratory infections caused by other respiratory pathogens such as Chlamydia pneumoniae [8, 10]. Thus, the diagnosis of M.
pneumoniae respiratory infection depends on
laboratory tests. However, culture and Gram
stain are not suitable for the diagnosis of M.
pneumoniae respiratory infection. The combined use of polymerase chain reaction (PCR)
and serology for the diagnosis of M. pneumoniae respiratory infection was recommended [9].
The incidence of M. pneumoniae in respiratory tract infections in Palestine was not
evaluated. The present study was conducted
to determine the prevalence of M. pneumoniae
infection among patients with respiratory tract
infection in Nablus District on the basis of
both serology (IgM and IgG) and PCR. To our
knowledge we are the first to study M. pneumoniae infections in our region. This study
will provide doctors with new information
about the prevalence of the M. pneumoniae in
Nablus District and availability of new diagnostic tools in our region they can use for correct diagnosis.
METHODS
Study design
In the present prospective cross-sectional
study, the patients were selected consecutively
among patients who visited or were admitted
to participating clinical settings and were diagnosed by physicians to have respiratory
tract infection. Patients with evidence of cancer, disorders of the pulmonary or cardiovascular system, and those who had received antibiotics active against M. pneumoniae were
excluded. Each patient or parents of patient
were informed about the research (informed
consent letter) before he/she gave their consent. The study proposal was approved by Protocol for Human Subjects Research Institutional Review Board (IRB( of An-Najah National University
Population
The study included patients with respiratory tract infections admitted to or visited the
participating clinical settings from September

2015 to April 2016. Participated clinical settings included: two governmental hospitals
(Al-Watani and Rafidya), the Palestinian Red
Crescent Center in town of Asira and AnNajah National University clinic at new campus. All of these clinical settings are in the
Nablus district.
A specially designed questionnaire was
used for data collection of the concerned patients. The questionnaire was filled by the researcher with the help of the treating physician
or an assistant nurse. The questionnaire included a set of questions concerning the following information: age, gender, place of residence, number of family members and smoking status, date of onset of the disease and time
of admission to hospital, clinical data (reported symptoms of cough, sputum production, vomiting, abdominal pain, headache, difficulty of breathing, shortness of breath and
fever ≥ 38 ◦C) and available laboratory findings such as CBC
Sample collection
At the time of hospital admission or first
visit to the clinic, from each patient, a throat
swab specimen was obtained with the help of
a doctor or a nurse. Medical stuff was asked to
provide the first serum specimen. Second serum specimens were taken after 7-15 days after initial sample collection when possible.
Throat swab specimens were placed in 2ml
normal saline and immediately placed on ice.
Samples were then transported to the laboratory and placed in sterile Eppendorf tubes and
stored at -20°C until the time of examination.
The serum specimens were placed in Eppendorf tubes and kept at -20°C until examination. In case of the presence of 2 serum
specimens, the first and second serum specimens were examined together.
DNA extraction and polymerase chain reaction for detection of M. pneumoniae in throat
swabs
DNA was extracted by a simple boiling
method as described by Waring et al. [11].
Aliquot of the sample lysate was then used directly for PCR amplification or kept at -20°C
until use.
DNA extractions from throat swab samples were tested for M. pneumoniae by nested
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PCR. The DNA sequences of the used primers
targeting the P1 adhesion were obtained from
Lam et al. [12]. PCR Ready mix (SIGMAALDRICH, USA) was used and PCR was performed with a total reaction mixture volume
of 25μl. The mixture contained 1x PCR buffer
[1.5 units Taq DNA polymerase, 10mM TrisHCl, 50 mM KCl, 1.5 MgCl2, 0.001% gelatin,
0.2mM
deoxynucleoside
triphosphate
(dNTP)]. A concentration of 0.8pmole/μl was
used for each of the used primers.
PCR reaction was performed using AmpliTaq Gold (Tprofessionla Biometra thermocycler, Germany). First and second rounds of
nested PCR were the same and carried out as
follows: one cycle of three minutes at 94°C
(for denaturation), 35 cycles of amplification
(one minute at 94°C [for denaturation] and
one minute at 64°C [for annealing] and one
minute at 64°C [for extension]), and final extension of 10 minutes at 72°C. A negative
control with no template was included and
specimens known to be positive were used as
positive control in each PCR run. PCR products were detected by 2% agarose gel electrophoresis with ethidium bromide staining and
the bands were visualized under UV light.
Detection of IgM and IgG antibodies
against M. pneumoniae
Enzyme-Linked Immunosorbent Assay
(NovaTec Immundiagnostica GmbH, Germany) was used for the determination of IgM
and IgG antibodies in serum specimens of the
patients. The procedure was carried out according to the manufacture instructions. Results were calculated in Nova Tec Unit (NTU)
and interpreted according to manufacturer instructions. The cut-off value was first calculated, which was equal to the mean of the absorbance value of the 2 wells to which cut-off
control was applied. Nova Tec Unit equal to
the patient absorbance value × 10 ÷cut-off.
The interpretation of the results using this unit
was negative when NTU was smaller than 11
and positive when it was bigger than 11.
Diagnosis of M. pneumoniae infection
In the present study, the laboratory diagnosis of M. pneumoniae infection was carried
out similar to what was previously described

[9]. Current or recent infection of M. pneumoniae was definitely diagnosed if at least
two of the following criteria were found:
1. positive PCR in throat swab specimen
2. positive IgM antibodies (in the first
and/or the second sample)
3. seroconversion or significant increase of
IgG antibodies (twofold increase), or IgG
titers >40 Nova Tec Unit
Probable cases of recent or current M.
pneumoniae infection were diagnosed when
only one of the three diagnostic criteria mentioned above was found.
Statistical analysis
A specialized statistician has performed
statistical analysis. SPSS version 21 for Windows was used for comparison of the prevalence of M. pneumoniae infections between
genders, different age ranges, and seasons. In
addition, the frequencies of clinical and laboratory parameters in patients with M. pneumoniae infections were compared with those
without such infection. In the statistical analysis, Chi-square and Fisher’s exact were used
for the comparison of frequencies in different
groups, while t-test was used for mean comparison in different groups. P value < 0.05
was considered significant.
RESULTS
Patients and specimens' collection
The study included 129 patients admitted
to or visited one of the participating clinical
settings with respiratory tract infection symptoms (diagnosed by physicians) from September 2015 to April 2016. The patients were inpatients and out patients at Al-Watani National Hospital (n=70), Rafidya Hospital
(n=11), out patients of An-Najah National
University clinic (n=18), and out patients in
Red Crescent center in Asira (n=30). All of
these clinical settings are in Nablus district.
Throat swabs were obtained at the time of admission or first visit from all of the 129 patients, and the first serum specimens were obtained from 103 patients. Second serum specimens were obtained from 16 of 103 patients
7 to 15 days later after the first serum sample
collection.
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Results of PCR and Serology
Table 1 shows the results of the examined
throat swab specimens by nested PCR and serum specimens by ELISA (IgM and IgG).
Among the 129 throat swab specimens, DNA
of M. pneumoniae was detected in 15(11.6%)
patients. ELISA assays for the detection of
IgM and IgG were carried out for 103 patients.
M. pneumoniae-specific IgM was detected in
4(3.9%) of the first serum samples. Collected
second serum (16) showed 2 additional IgM
positive samples. Therefore, 6(5.8%) of the

involved patients had positive IgM in the first
and/or second serum specimen.
In the first serum specimen of 103 patients, IgG antibody was detected in 47
(45.6%), while in the collected (16) second serum specimen, IgG antibodies were detected
in 11(68.8%) cases. No seroconversion was
detected (negative IgG in the first and positive
IgG in second), thus the patients with positive
IgG in the first and/or in the second serum
specimen were 47 (45.6%).

Table (1): PCR and ELISA (IgG and IgM) findings in tested samples.
Patients with
positive results
in 1st &/or 2nd a
serum specimens No. (%)
6(5.8)
47(45.6)

Positive results in 2nd
serum
specimens
No. (%)
2 (12.5)c
11(68.8)

Positive results in 1st
a Serum
specimens
No. (%)
4(3.9)
47(45.6)

Positive
PCR
No. (%)
15(11.6%)
-

No. of the examined specimens
No. (%)

Assay

129
103+16b
103+16

PCR
ELISA-IgM
ELISA-IgG

a

1st , First serum sample; 2nd , second serum sample
103 first serum sample and 16 second serum sample
c
percentage calculated using 16 second serum sample
b

Patients diagnosed with M. pneumoniae infection
According to the diagnostic criteria of M.
pneumoniae current infection, mentioned in
the methods, 10 (7.8%) patients were diagnosed with the infection. Table 2 shows the
PCR, IgM and IgG results of the 10 diagnosed
cases. M. pneumoniae bacterium was detected
by PCR in throat swabs in all of these 10 patients diagnosed with M. pneumoniae current
infection, indicating high sensitivity of PCR.
IgM antibodies were detected in 4 cases
(3.9%) in the first serum sample. Seroconversion of IgM antibody (negative IgM in the first
and positive IgM in second) was detected in
one patient indicated by number 9 in Table 2.
IgG antibodies were positive in all of the 10
cases in the first serum sample. A significant
increase (twofold increase) in IgG antibodies
was detected in one case (patient number 9).
PCR appears to be more sensitive (100%)
compared to IgM in the first serum specimen
(40%).

Eight (7.7%) patients did not meet the diagnostic criteria of current M. pneumoniae infection and were considered as probable cases.
Among these patients, 5 cases (number 11-15)
had positive PCR without serology confirmation. Seroconversion of IgM was detected in
one case (patient 16) with negative PCR and
no significant increase in IgG titer. In 4 cases
(number 11, 12, 17, 18) IgG antibodies were
detected in 4 first serum samples.
Evidence of possibly previous M. pneumoniae infection was detected in 33(25.6%)
patients who were negative by PCR and negative for IgM in the first and in the second samples, but IgG antibodies were positive in the
first or/ and the second samples.
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Table (2): Patients diagnosed with current, probable, or possible previous M. pneumoniae infection.
First serum sample
Second serum sample
PCR
IgM
IgG
IgM
IgG
(NTU)
( NTU)
( NTU)
( NTU*)
Patients with current M. pneumoniae infection
1
P*
N*
P(43)
NA*
NA
N
2
P
P(54)
NA
NA
P (28.3)
3
P
P(97)
NA
NA
N
4
P
P(102)
NA
NA
P(12.6)
5
P
P(15)
NA
NA
6
P
N
P(50)
NA
NA
7
P
N
P(83)
NA
NA
8
P
P (23.6)
P(12)
NA
NA
9
P
N
P (27)
P (15)
P(74)
10
P
P (35)
P (15)
NA
Na
Patients with probable M. pneumoniae infection
11
P
NA
N
P(28)
NA
12
P
NA
N
P(15)
NA
13
P
NA
N
N
NA
14
P
NA
N
N
NA
15
P
NA
N
N
NA
16
N
N
P(34)
P(13)
P(31)
17
N
N
P(49)
NA
NA
18
N
N
P(40)
NA
NA
Patients with evidence of possible M. pneumoniae previous infection
19-26
N
N
P(15-28)
N
P(15-30)
27-51
N
N
P(12-37)
NA
NA
Patients with no evidence of M. pneumoniae infection
52-57
N
N
N
N
N
58-129
N
N
N
NA
NA
Sample
number

*P, positive; N, negative; NA, not available; NTU, Nova Tec Unit.

No evidence of M. pneumoniae infections
by any of the applied methods (both PCR and
ELISA) were found in 78(60.5%) of the studied cases.
M. pneumoniae infection in relation to different factors
The infection rate in males (8.6%) was
found to be insignificantly (P =0.753) higher
than females (7.1%). Patients’ age included in
the present study ranged from 1 to 91 years
with a mean age of 32 years.

The highest percentage of M. pneumoniae
respiratory infection (11.3%) was found in patients with the age ranged 25-64 years, which
was insignificantly higher than that of patients
ranging 0-9 years (9.1%, P=0.663) and 10-24
years (7%, P=0.383). Furthermore, M. pneumoniae infection was not diagnosed in 12 patients with age ≥ 65 years.
Table 3 shows the frequency of clinical
signs and symptoms reported in patients with
or without M. pneumoniae infection. No significant difference was found in the compari-
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son of frequencies of signs and symptoms between patients with M. pneumoniae infection
and those with other causatives of respiratory
infections, however, some variations were
noted. Cough, sputum production, fever, and
abdominal pain were insignificantly higher in

cases diagnosed to have M. pneumoniae infection. On the contrary, headache, difficulty of
breathing, shortness of breath, vomiting, and
average days of disease onset were insignificantly lower in patients with M. pneumoniae
infection.

Table (3): Signs and symptoms among patients with or without M. pneumoniae infection.
Signs and symptoms
Cough
Sputum production
fever ≥ 38 ◦C
Abdominal pain
Headache
Difficulty of breathing
Shortness of breath
Vomiting
Average days of disease onset

M. pneumoniae positive (n= 10)
No. (%)
10 (100)
8(80)
6(60)
4(40)
4(40%)
8(80%)
8(80%)
2(1.6%)
6.11± 2.83

A comparison of means of parameters of
complete blood count (CBC) among patients
with M. pneumoniae infection and among
those without this infection was carried out. In
patients with M. pneumoniae infection, means
of WBC count (7± 3.3), lymphocyte percentage (28.5± 13.5), granulocytes percentage
(68.2±14.3) and platelets count (278.3±88.9)
did not differ significantly from means of
those patients without M. pneumoniae infection, where means of WBC count, lymphocyte
percentage, granulocytes percentage and
platelets count were 7.4± 3.2, 28.9±13.7 ,
67.4±14.2 and 280.1±70.3, respectively.

M. pneumoniae negative (n=119)
No. (%)
110 (92.4)
93 (78.2)
54 (45.4)
28 (23.5%)
76(63.9%)
98(82.4%)
101(84.9%)
27(20.9%)
6.7± 2.45

P value
0.287
0.212
0.367
0.627
0.563
0.602
0.653
0.125
0.526

Results of the CBC were compared to
normal ranges in different ages using reference ranges [13, 14] to determine if there were
any increases in the CBC values as shown in
Table 4. In patients with infection by respiratory pathogens other than M. pneumoniae, the
rates of increase of WBC (8.4%) and of granulocytes (40.3%) were significantly higher
(P= 0.006 and <0.001, respectively) than that
in patients with M. pneumoniae infection. On
the contrary, the percentage of increase in
lymphocytes among patients diagnosed with
M. pneumoniae infection (20%) was significantly higher than that in patients infected by
other respiratory pathogens (15.9%).

Table (4): Frequency of increase in CBC parameters in patients with M. pneumoniae infection and
among those with other infectious agents.
Parameters
Increase WBC count
Increase lymphocyte
Increase granulocytes
Increase platelets count

M. pneumonia positive
N=10
No. (%)
0(0)
2(20)
3(30)
1(10)

Among the 10 patients with M. pneumoniae infection, 7 (70%) were clinically diagnosed with upper respiratory tract infection

M. pneumoniae negative
N=119
No. (%)
10 (8.4)
19(15.9)
48(40.3)
6(5.1)

P value
0.006
0.001
<0.001
0.133

and the rest 3 cases (30%) were diagnosed as
bronchitis cases. The frequency of upper res-
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piratory tract infection caused by M. pneumoniae (70%) was close to that caused by
other pathogens (72.3%). However, bronchitis rate in patients infected by M. pneumoniae
(30%) was insignificantly (P=0.334) higher
than those infected by other pathogens
(18.5%). On the contrary, frequency of pneu-

monia caused by M. pneumoniae (0%) was insignificantly lower (P=0.605) than other infectious agents (9.3%).
M. pneumoniae infection frequency was
highest (10.4%) during winter followed by
spring (4.5%), and no cases were detected
during autumn. These variations were insignificant (Table 5).

Table (5): Seasonal distribution of M. pneumoniae infection.
Non- M. pneumoniae
No. (%)
69(89.6)
42(95.5)
8(100)

M. pneumoniae infection
No. (%)
8 (10.4)
2(4.5)
0 (0)

Among the included 129 patients, 15 had
diabetes mellitus, 2 had anemia, 20 had hypertension, and 22 were smokers as shown in Table 6. No significant association between M.
pneumoniae
infection
and
smoking
(P=0.230), anemia (P =0.85), hypertension (P
=0.520), diabetes mellitus (P = 0.762) or number of siblings (P = 0.879) were found. The

Total number
77
44
8

Season
Winter
Spring
Autumn

finding of a limited number of patients diagnosed with M. pneumonie infection makes it
difficult to link such risk factors to this infection; however, it is worth noting that smoking
status (13.6%) is a more pronounced risk factor in M. pneumoniae infection compared to
other studied risk factors.

Table (6): Risk factors for acquiring M. pneumoniae infection.
Risk factor
Smoking
Hypertension
Diabetes mellitus
Mean No. siblings
Anemia

No. positive
22
20
15
129
2

M. pneumonia
No.(%)
3(13.6)
1(5)
1(6.7)
4.5±1.1
0(0)

DISCUSSION
Difficulty and high costs of diagnosis of
M. pneumoniae infection by laboratory methods hinder the determination of its prevalence
in most third world countries. To our
knowledge, the present study represents the
first determination of the prevalence of M.
pneumoniae in respiratory tract infections in
adults and children in Nablus district. For
more accurate diagnosis of M. pneumoniae infections, a combination of PCR and serological testing using ELISA assay for the detection of IgM and IgG specific antibodies were
used.
In the present study, 10 patients (7.8%)
were diagnosed with current M. pneumoniae

Non M.pneumoniae
No.(%)
19(86.4)
19(95)
14(93)
4.7±1.4
2(100)

P Value
0.230
0.520
0.672
0.762
0.850

respiratory tract infection and 8 patients were
diagnosed to be probably infected with M.
pneumoniae. In a study carried out in Malaysia during 2011, a close percentage of M.
pneumoniae infection rate (6.5%) was determined by serology among 17–80 years-old patients with community acquired pneumonia
[15]. Similar findings were also reported from
Iran in a study conducted during 2009 to 2010,
where 6.15% of patients were diagnosed with
M. pneumoniae respiratory tract infections
based on PCR, culture and serology findings
[16]. A higher frequency (21.6%) of M. pneumoniae in respiratory tract infections was reported by a study carried out in 12 teaching
hospitals in Beijing during 2010 to 2011 for
adult and adolescent patients (≥ 14 years of
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age) with radiographically confirmed community acquired pneumonia (CAP). The findings
of this study were based on IgM antibody testing, florescent quantitative PCR, and culture
[17]. In a previous research carried out in
Greece, M. pneumoniae infection was diagnosed as the only pathogen in 11.1% of cases
of children with respiratory tract infection
[10]. Variations in the frequency of M. pneumoniae infection rate in the respiratory tract in
different geographical regions are expected to
occur due to seasonal climate differences in
temperature, geographic features, applied diagnostic methods, types of collected specimens, population spread on area, and antibiotics application policy [18].
In the present study, all diagnosed cases
of M. pneumoniae infection were PCR positive and only 4(40%) were positive by IgM
ELISA in the first serum specimen. Thus, the
sensitivity of nested PCR (100%) was higher
than that of serological testing of IgM (40%)
in the first serum specimen. In another study,
M. pneumoniae IgM assay determined by capture ELISA was found to show a sensitivity of
66.7% in the first serum sample and conventional PCR sensitivity was 75% [9]. Variations in sensitivity of various testing techniques could be due to variations in the sensitivity of ELISA kits or PCR, sample type, and
patient age (IgM more sensitive in children).
In the present study, the highest percentage of M. pneumoniae respiratory infection
(11.3%) was found in patients within the age
range of 25-64 years. This was followed by
age range 0-9 (9.1%) and 10-24 (7%).
In
2015, Keping Chen et al. [19] reported that M.
pneumoniae infection was the most predominant (40.8%) in school-aged children 7-14
years. However, a very low prevalence of M.
pneumoniae infection rate (1%) based on RTPCR was found among Iranian children with
acute respiratory infections during 2003 to
2004 [20]. During 2010-2015, a study in England found M. pneumoniae infection is predominantly found in children and adults <44
years of age [21]. Variations in the frequency
of this infectious bacterial agent among different age groups may be due to the frequency of
close contact with infected individuals as well
as the development or decline of immune status in relation to age.

In the current study, the infection rate was
highest during winter (10.4%) followed by
spring (4.5%). It was reported that M. pneumoniae infection occurs most commonly during fall and winter [18]. On the contrary, a
study in China reported that M. pneumoniae
infection was relatively high in summer and
autumn (45.08% and 47.14%, respectively)
and relatively low in spring (38.3%) and winter (35.5 %) [19].
In our study, all of the 10 patients with M.
pneumoniae infection had cough, thus coughing was the most common symptom. No significant difference was found in signs and
symptoms between patients with M. pneumoniae infection and with other causatives of
respiratory tract infections. Consistent with
our findings on associated symptoms, a previous study reported fever and cough to be the
most common symptoms (both 84%) in patients with M. pneumoniae infection [10].
Medjo et al. [3] found that cough was more
frequent in children with Mycoplasma pneumoniae pneumonia compared to children with
pneumonia caused by other pathogens.
In the present study, patients with infection by respiratory pathogens other than M.
pneumoniae possessed rates of increase of
WBC (8.4%) and of granulocytes (40.3%) significantly higher (P= 0.006 and <0.001, respectively) than those in patients with M.
pneumoniae infection. On the other hand, the
percentage of increase in lymphocytes among
patients diagnosed to have M. pneumoniae infection (20%) was significantly higher than
that in patients infected by other respiratory
pathogens. It was reported in Beijing-China
[17] that the mean of lymphocytes was
19.6±10.64 in patients with M. pneumoniae
infection, which is insignificantly (P=0.614)
higher than in patients without M. pneumoniae
infection (18.5 ± 7.14). The lower frequency
of increase of WBCs among patients infected
by M. pneumoniae may be due to the lower
antigenic stimulation caused by M. pneumoniae as this bacterium is the smallest free
live one and possesses a very low division
rate.
Among the investigated risk factors in the
present study, the highest frequency of association with M. pneumoniae respiratory infection was smoking (13.6%). Similar findings
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were reported by [22] as smoking was reported to be strongly associated with M. pneumoniae respiratory infections.
Two limitations of the present study
should be mentioned. The first limitation is
number of confirmed cases is small and consequently may limit the value of statistical
analysis results. The second limitation is the
small number of second serum specimens.
Although we tried hard to obtain second serum specimens, many patients refused to
come again after the recovery of their health
for the second serum specimen. However, this
problem is not expected to affect the results of
the study to a considerable level because the
results also depend on PCR. Nested PCR
technique is very sensitive in detecting the
pathogen in the acute phase before the development of antibodies. In our results, only 5
cases out of 129 (3.9%) were PCR positive
without detecting a diagnostic immune response and these were called probable cases of
infection.
In summary, M. pneumoniae plays an important role as an etiological agent of respiratory tract infections in Nablus district. M.
pneumoniae respiratory infection rate was
highest in the age range of 25-64 years. Most
cases of M. pneumoniae respiratory infection
were diagnosed during winter followed by
spring. With the exception of an increase in
lymphocyte percentage, symptoms, and signs
appear to have a limited diagnostic value of M.
pneumoniae infection.
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